Index A
- Abciximab 702
- in ischemic stroke 411
- in unstable angina 857
- Abdomen
- abscess of, postoperative 254-255
- acute 1105
- examination of 35
- in intestinal tract obstruction 1114
- surgery on 1105
- pain after 264
- Abdominal aorta, aneurysm of 934-937
- screening for 47t
- Abscess
- abdominal, postoperative 254-255
- amebic 1130
- colonic 1057
- hepatic 1129-1130
- ischiorectal 1077-1078
- paravertebral 764
- perianal 1077-1078
- in Crohn's disease 1065
- splenic 1133
- for muscle mass measurement 520
- Absorption dressings, in pressure sore treatment 1273t
- Abuse, elder 149-155 (see also Elder abuse)
- Acarbose 73, 633, 635t
- Accelerated junctional rhythm 889-890
- (see also Arrhythmias)
- Accidents
- alcoholism and 335
- motor vehicle (see also Driving)
- mortality rates for 13t
- pancreatic injury with 1130
- prevention of 52
- rates of 231-233, 232f
- prevention of 52
- Acebutolol
- in hypertension 843t
- ACE inhibitors (see Angiotensin-converting enzyme inhibitors)
- Acetabular fractures 225
- Acetaminophen 389
- alcohol interaction with 335
- in osteoarthritis 491
- Acetazolamide
- in glaucoma 1300t
- in metabolic alkalosis 587
- Acetohexamide 632t
- Acetylcholine
- in glaucoma 1300t
- Acetylcholine receptor, antibodies to 520, 521
- Acetylsalicylic acid (see Aspirin)
- Achalasia 1035-1036
- Achilles tendon
- bursitis 547t
- enthesopathy 547t
- Achlorhydria 1041
- Acid-base disorders 584-588, 585t (see also Acidosis; Alkalosis)
- Acid breath test 1104
- Acidosis
- aging kidney and 954
- alcoholic 639-640
- diabetic 639-640
- metabolic 585-586, 585t
- in renal failure 962
- respiratory 587
- Acid perfusion test 1040
- Acitretin 1255
- Acne rosacea 1248-1249
- Acoustic neuroma 184t, 1341-1342
- Acquired immunodeficiency syndrome (AIDS) 1378-1382, 1381t
- gastrointestinal infections in 1088
- Acrochordons 1242t
- Acroparesthesias, of hand 535
- Acrophobia 327
- ACTH (adrenocorticotropic hormone)
- (see Corticotropin)
- Actinic keratoses
1236, 1238, 1276-1277
- Actinic purpura 1237
- Activated protein C resistance 690
- Activin 597
- Activities of daily living
- in comprehensive geriatric assessment 42-43, 43t, 44t
- instrumental 42-43, 43t, 45t
- occupational therapy and 288, 291t
- Acupuncture 278
- Acute care for the elderly (ACE) unit 54
- Acute stress disorder 328
- Acute tubular necrosis 960, 961t
- Acyclovir 1376t-1377t
- in herpes zoster infection, 1018, 1260
- ADAM (Androgen Deficiency in the Aging Male) syndrome 1167, 1171-1174, 1172t
- Addiction
- alcohol (see Alcoholism)
- opioid 393
- screening for 47t
- Adefovir1377t
- Adenocarcinoma (see also Cancer)
- bile duct 1151-1152
- cervical 1205-1206
- colorectal 1141-1144
- dementia in 370
- esophageal 1134-1136
- gastric 1137-1139
- of lungs 800-806, 801t, 802t
- pancreatic 1145-1148
- prostate 1183-1186
- renal 987-991, 989t
- small-intestine 1139-1140
- Adenoma
- hepatic 1148
- parathyroid 578, 580
- pleomorphic 1030
- thyroid 647, 653
- Adenosine
- aging effect on 60t
- in paroxysmal supraventricular tachycardia 889
- for stress testing 827t, 828, 830
- Adherence, to drug therapy 69-70
- Adjustment sleep disorder 454
- ADLs (see Activities of daily living)
- Adrenergic blocking agents (see Alpha blockers; Beta blockers and specific agents)
- Adrenocorticosteroids (see Corticosteroids)
- Adrenocorticotropic hormone (see Corticotropin)
- Adriamycin 747t
- Adult care home (see Board-and-care facilities)
- Adult respiratory distress syndrome (ARDS) 788, 790
- Advance directives 54, 98, 134-135
- for stroke patient 399
- surgery and 242
- Advanced sleep phase syndrome 454, 459
- Adverse drug reactions (see Drugs, adverse reactions to)
- Adynamic ileus 1116
- Aerobic capacity 820
- Affective disorders (see Depression)
- Afterload 816t, 817-818
- Age-related macular degeneration 1304-1305
- Aging
- acceleration of 8-9
- anorectal changes with 1080-1081
- bone changes with 474
- biology of 3-9
- cardiovascular changes with 813-822, 814t-815t, 896, 902
- cellular (molecular) 5-6
- definition of 3
- demographics of 9-23 (see also Demographics)
- digestive changes with 1095-1096
- vs. disease 4
- electrocardiographic changes with 896
- gastrointestinal tract changes with 1000-1006
- healthy (successful) 3-4
- hematologic changes with 672-673
- hepatic changes with 1003-1005
- hormonal deficiency and 656t
- immune system changes with 1351-1359, 1352t, 1352t
- laboratory value changes with 1384t
- mental health and 307-310
- musculoskeletal system changes with
467-472, 469t
- nasal changes with 1344
- nervous system changes with 380-383, 381t, 382t
- normal 3
- ocular changes with 1284-1293, 1285f
- oral changes with 1000-1001, 1024
- pancreatic changes with 1003, 1095-1096
- pulmonary changes with 753-757
- renal changes with 951-954
- resources on 1409-1411
- sexual function changes with 1158-1159
- skin changes with 1231-1238, 1232t
- sleep changes with 451-452
- speech changes with 424-425
- successful (healthy) 3-4
- surgical risk and 243
- theories of 6-9
- Agitation
- vs. anxiety 324
- in delirium 350, 356
- in dementia 372
- in dying patient 121-122
- Agnogenic myeloid metaplasia 711-714, 713t
- Agoraphobia 327
- Air-fluidized bed 1269t
- Air mattress 1268t
- Air travel
- COPD and 786
- Airway, obstruction of, 779-787 (see also Chronic obstructive pulmonary disease)
- during sleep 460-461
- Akathisia, tardive 447
- Albumin
- blood 572
- age-related changes in 1378, 1384
- in malnutrition 600, 600t
- stress effect on 596
- during weight reduction 605
- Albuterol
- aging effect on 60t
blocker interaction with 68t
- in COPD 786, 787
- Alcohol (see Alcoholism)
- abuse of (see Alcoholism)
- blood 334, 336
- in cardiovascular disease prevention 48t
- driving and 237-238
- drug interactions with 335
- in insomnia 457
- ketoacidosis and 639-640
- sexual function and 1165
- sleep disorders with 451t
- urinary incontinence with 967t
- Alcohol dehydrogenase 334
- Alcoholism 333-340
- dementia in 370
- malnutrition and 598, 336
- medical complications in 336t
- patient assessment of 30
- screening for 47t, 336-337
- subdural hematoma and 422
- thiamine supplementation in 590
- tremor in 438t
- withdrawal treatment for 336, 338-339
- tremor with 438t
- Aldosterone 953-954
- receptor blockers
- in hypertension838t
- Aldosteronism, hypertension with 837
- Alendronate
- in osteoporosis 479-480
- in Paget's disease of bone 485t
- Alginate dressings 1271
- Alkaline phosphatase
- age-related change in 1384t
- in fracture evaluation 217
- Alkalosis
- metabolic 586-587
- respiratory 587-588
- Allergic contact dermatitis, venous ulcers and, 1253-1254
- Allergy
- age-related changes in 1357
- insulin 636
- nasal 1344, 1345
- vancomycin 1375t
- Allopurinol 496
- Alopecia 1234-1235
1-antitrypsin deficiency 787
- Alpha agonists
- in bladder incompetence 978
- in glaucoma 1297, 1300t
- in priapism 1190
- sleep disorders with 451t
- urinary incontinence with 967t
- Alpha-beta blockers, in hypertension 843t
- Alpha blockers
- in benign prostatic hyperplasia 1180, 1182
- in bladder outlet obstruction 979
- diuretic interaction with 69t
- in hypertension 842t
- in prostatitis 1189
- urinary incontinence with 967t
- Alprazolam, adverse effects of 65t
- Alprostadil 1170
- ALS (see Amyotrophic lateral sclerosis)
- Aluminum hydroxide
- in diarrhea 1091t
- in hypocalcemia 575
- Alveolar bone
- loss of 1023
- Alzheimer's disease 357, 370t (see also Dementia)
- vs. HIV-associated dementia 1381t
- immune senescence and 1359
- mortality rates for 13t
- resources on 1411
- Amantadine 1377t
- in influenza 770
- in parkinsonism 439, 449t
- Amaurosis fugax 1307
- in carotid artery atherosclerosis 403
- in giant cell arteritis 508
- Ambulation exercises 273, 274f
- after stroke 281-282
- Amebic abscess 1130
- Amifostine 719
- Amikacin 1367t
- Amiloride
- in hypertension 839t
- Aminoglutethimide 1226t
- Aminoglycosides 1367t
- fall risk and 197t
- tinnitus with 1330t
- Aminopenicillin 1368t (see also Amoxicillin; Ampicillin)
- Amiodarone 888t
- drug interactions with 68t
- in heart failure 910
- hyperthyroidism with 647-648
- Amitriptyline
- adverse effects of 64t, 66t
- in pain management 394t
- Amlodipine
- in heart failure 908
- in hypertension 843t
- in stable angina 857
- Amoxicillin 1368t
- in endocarditis prophylaxis 881t
- in Helicobacter pylori infection 1047
- Amphetamines, sexual function and 1163t
- Amphotericin B 1366,
1376t
- in infective endocarditis 884t
- Ampicillin
- in acute cholangitis 1127
- in endocarditis prophylaxis 881t
- in infective endocarditis 884t
- Amputation, leg
- pain after 286
- phantom limb after 286-287
- prosthesis for 285-286
- rehabilitation after 284-287
- stump conditioning after 285-286
- Amylase, in pancreatitis 1131
- Amyloid
- cardiac 813, 815, 914
- Amyloid angiopathy
- intracerebral hemorrhage and 419
- subarachnoid hemorrhage and 416, 417
- Amyloidosis
- cardiac 813, 815, 914
- renal 956, 957
- small-intestine 1103
- Amyotrophic lateral sclerosis 516t
- Anagrelide 707
- Analgesia388-396
- in dying patient 116
- nonpharmacologic
- in dying patient 117
- pharmacologic 388-396 (see also specific drugs and Anesthesia)
- adjuvant drugs in 117
- adverse effects of 64t, 74
- aging effects on 60t
- hepatic metabolism of 58t
- patient-controlled 391
- Anal wink 974
- Anasamycin 1375t
- Anastrozole 1226t
- Androgen(s) (see also specific hormones)
- deficiency of 1169t, 1171-1174, 1172t
- in myelofibrosis 713
- sexual function and 1163t, 1164t
- Anemia 674-687, 674t
- aplastic 682-683, 683t
- chloramphenicol-induced 1373t
- of chronic disease 678-679
- in chronic leukemia 730
- in chronic renal failure 964
- folate deficiency 686-687
- hemolytic 679-682, 680t
- iron deficiency 675-677
- macrocytic 674t, 684-687
- in malabsorption 1101
- of malignancy 679
- microcytic 674t, 675-677
- in multiple myeloma 735
- in myelodysplastic syndromes 740
- normocytic 674t, 677-684
- pernicious 685, 1041
- of primary autonomic failure 683
- refractory 740
- sideroblastic 683-684
- unexplained 684
- vitamin B12 deficiency 592, 685-686
- Anergy 601
- Anesthesia 255-264
- age-related changes and 256t-257t, 262
- disease effects on 260t-261t
- drug interactions with 258t
- intraoperative considerations in 259-262
- preoperative considerations in 255-258, 258t
- regional 259
- for postoperative pain 263
- Anesthetics
- local
- in pain management, 393, 394t
- Aneurysm 933-942
- aortic 933-937
- abdominal 934-937, 1111-1112
- screening for 47t
- rupture of 935, 936
- thoracic 933-934
- in aortic dissection 939
- carotid 938
- cirsoid (racemose), bleeding in 1110
- femoral 938
- popliteal 937-938
- subarachnoid hemorrhage and 416, 418
- Angina pectoris 855-858 (see also Coronary arteries, disease of)
- abdominal aneurysm and 937
- coronary artery bypass grafting and 942-944
- in hypertension 836
- in hyperthyroidism 649
- percutaneous transluminal coronary angioplasty and 944-947
- rehabilitation for 278-279, 280t
- sexual activity and 1159
- unstable 855, 857-858
- Angiodysplasia
- colonic 1057-1058
- bleeding in 1111
- gastrointestinal 1051-1052
- Angiography
- in aortic dissection 941
- coronary 832, 832t
- fluorescein
- age-related macular degeneration and 1305
- in diabetic retinopathy 1303
- in ischemic stroke 409, 414
- mesenteric, in angiodysplasia 1058
- pulmonary, in pulmonary embolism 774, 775
- risks of 409
- in subarachnoid hemorrhage 418
- Angioma, cherry, of skin 1242t
- Angioplasty 944-949
- in ischemic stroke 410
- in myocardial infarction 860, 861, 863t
- in peripheral atherosclerosis 919
- Angiotensin-converting enzyme (ACE) inhibitors
- diuretic interaction with 69t
- in heart failure 906-907
- in hypertension 842t
- after myocardial infarction 862t
- in myocardial infarction 859
- urinary incontinence with 967t
- Angiotensin II
- age-related changes in 954
- aging effect on 60t
- Angiotensin II receptor blockers
- in heart failure 907-908
- in hypertension 842t
- Angular cheilitis 1019
- Anion gap 585
- Anisoylated plasminogen-streptokinase activator complex (APSAC) 700-701
- Ankle
- disorders of 545t
- range of motion of 270t
- swollen 28t
- Ankylosis 488
- Anomia 425
- Anorectum (see Anus; Rectum)
- Anorexia
- in dying patient 118
- in malnutrition 597-598, 597t
- Anorexia nervosa 598
- Anorexia tardive 598
- Anorgasmia 1178
- Anoscopy 1009-1010
- in hemorrhoids 1075
- Anserine bursitis 498
- Antacids
- digoxin interaction with 68t
- in peptic ulcer disease 1045-1046
- Antiandrogens, in prostate cancer 1186
- Antiarrhythmics 888t (see also specific drugs)
- adverse effects of 887
- dosage adjustment for 70
- fall risk and 197t
- in heart failure 910
- in pain management 394t
- Antibiotics 1367t-1375t, 1367t-1375t (see also specific drugs and drug classes)
- in acute cholangitis 1127
- in catheter-related infection 987
- in cellulitis 1253
- in COPD 787
- colitis with 1066-1068
- in diarrhea 1091, 1091t
- diarrhea with 1066-1068
- in diverticulitis 1055t
- elimination of 58t, 1378
- in endocarditis 882, 883t-884t
- in Helicobacter pylori infection 1047
- in osteomyelitis 487
- in periodontal disease 1016
- in pneumonia 761, 762t
- prophylactic, in endocarditis 881t
- in prostatitis 1188
- pruritus ani with 1073-1074
- pseudomembranous colitis with 254
- in rosacea 1249
- in sinusitis 1348
- in urinary tract infection 984-985
- Antianxiety drugs 324
- Antibodies
- age-related changes in 1352t, 1355-1356
- anti-acetylcholine receptor 520, 521
- anti-calcium channel 522, 523
- anticardiolipin 691, 921-922
- antigliadin 1090
- anti-HIV 1379-1380
- anti-Jo-1 527
- antinuclear
- in glomerulonephritis 958
- in nephrotic syndrome 956
- in systemic lupus erythematosus 504
- in Wegener's granulomatosis 510
- antiparietal cell 1041
- antiphospholipid 691
- auto- (see Autoantibodies)
- drug-induced 680, 680t
- lupus anticoagulant 691
- monoclonal, in breast cancer 1227-1228, 1227t
- in thymoma 521
- thyroid 645
- Anticardiolipin antibody 691, 921-922
- Anticholinergic drugs
- anxiety and 324t
- in COPD 786, 787
- delirium with 352t
- drug interactions with 68t
- in parkinsonism 440
- sexual function and 1163t, 1164t
- urinary incontinence with 967t
- Anticholinesterases, in myasthenia gravis 521
- Anticholinesterase inhibitors
- sleep disorders with 451t
- Anticoagulants 695t, 697-702, 699t, 701t (see also Heparin; Warfarin)
- aging effects on 60t
- in atrial fibrillation 891-892
- in deep vein thrombosis 928-929
- dosage adjustments for 71
- in ischemic stroke 410-411, 415
- after myocardial infarction 862t
- prophylactic 778
- in pulmonary embolism 777
- vitamin E as 590
- Anticonvulsant hypersensitivity syndrome 1241t
- Anticonvulsants
- delirium with 352t
- in pain management 394t
- Antidepressants 72-73, 320 (see also specific drugs)
- adverse effects of 63t
- delirium with 352t
- driving and 236
- for dying patient 120-121
- exercise and 305
- in generalized anxiety disorder 324
- heart disease and 321
- in insomnia 458t
- in pain management 393, 394t
- sexual function and 1163t, 1164t
- tricyclic 72-73, 320
- drug interactions with 69t
- sexual function and 1163t, 1164t, 1167, 1177
- urinary incontinence with 967t
- Antidiabetic drugs 632t
- Antidiarrheal drugs 1091-1092, 1091t
- Antidiuretic hormone (ADH, vasopressin)
- age-related changes in 561
- Antiemetics
- in chemotherapy-induced nausea and vomiting 719
- for dying patient 118
- Antifungal drugs 1376t (see also specific drugs)
- in oral candidiasis1018
- Antigliadin antibodies 1090
- Antihistamines (see also specific drugs)
- adverse effects of 63t
- benztropine interaction with 69t
- in dermatitis 1250
- driving and 236
- in insomnia 458t
- sexual function and 1164t
- in skin disorders 1243
- urinary incontinence with 967t
- Antihyperglycemic drugs 629, 632t, 635t
- combinations of 636
- Antihypertensives 839t, 840t, 841t, 842t, 842t, 843t, 843-844 (see also specific drugs)
- in chronic renal failure 843t, 963
- in diabetes mellitus 843t
- efficacy of 70
- exercise and 305
- in heart failure 843t
- in hypertension 841t
- sexual activity and 1160, 1168t
- sleep disorders with 451t
- Anti-inflammatory drugs
- nonsteroidal (see Nonsteroidal anti-inflammatory drugs and specific drugs)
- Antimalarials
- sexual function and 1164t
- Antimicrobial drugs 1366-1378 (see also Antibiotics)
- Antineoplastic agents 717-719, 720t-721t (see also Chemotherapy, cancer)
- acute leukemia with 725
- myelodysplastic syndromes with 739
- tinnitus with 1330t
- Antinuclear antibodies
- in glomerulonephritis 958
- in nephrotic syndrome 956
- in systemic lupus erythematosus 504
- in Wegener's granulomatosis 510
- Antioxidant(s)
- in lipoprotein disorders 623
- vitamin C as 593, 594
- vitamin E as 590
- Antiparkinsonian drugs 437-440, 449t
- delirium with 352t
- dosage adjustments for 71
- Antiphospholipid antibody syndrome 691
- Antiplatelet drugs 701-702
- in ischemic stroke 411
- Antipseudomonal penicillin 1368t
- Antipsychotics 332-333 (see also specific drugs)
- in agitation 356
- in alcohol withdrawal 338-339
- delirium with 352t
- in dementia and behavior disorders 71, 375-376
- dosage adjustment for 71
- fall risk and
197t
- in mania 321
- parkinsonism with 444t
- sleep disorders with 451t
- tardive dyskinesia and akathisia with 447
- urinary incontinence with 967t
- Antispasmodics
- adverse effects of 64t-65t
- in diverticular disease 1055t
- Antithrombin
- deficiency of 691
- in disseminated intravascular coagulation 692
- Antithyroid drugs 651-652
- Antiviral drugs 1376t-1377t
- in HIV infection 1381
- Anus (see also Rectum)
- abscess of 1077-1078
- age-related changes in 1080-1081
- disorders of 1073-1080, 1077f
- examination of 35
- fissures of 1076, 1077f
- fistula of 1078
- pruritus of 1073-1074
- rectal prolapse through 1079-1080
- removal of, sexual activity after 1162-1163
- spasms of (proctalgia fugax) 1079
- tumors of 1144-1145
- Anxiety
- occupational therapy for 290
- Anxiety disorder(s) 322-327, 323t
- vs. delirium 350
- dementia and 323, 323t
- depression and 324
- drug-related 323t
- drugs for 71-72
- exercise and 305
- in erectile dysfunction 1167-1168, 1171
- generalized 324
- medical disorders and 323t
- in mental status examination 347
- in parkinsonism 435
- Aorta
- aneurysm of 933-937
- screening for 47t
- dissection of 938-942, 940t
- Aortic arch syndrome 1308
- Aortic pulse wave 816t, 817-818, 818f
- Aortic valve
- percutaneous balloon valvuloplasty for 949-950
- regurgitation
- acute 867-869
- chronic 869-871
- replacement of 947-949
- stenosis 864-867
- anesthesia effects of 260t
- angiodysplasia and 1052
- in infective endocarditis 878
- murmur of 824
- Aortography (see Angiography)
- Aphasia 425-427, 424t, 426t
- Aphthous ulcers 1019, 1020t-1021t
- Aplastic anemia 682-683, 683t
- chloramphenicol-induced 1373t
- Apnea
- sleep 460-462
- Apocrine glands 1234
- Apomorphine 440
- Apoptosis 6
- Appendicitis 39, 1123
- Apraclonidine 1300t
- Apraxia 344-345, 349
- speech 428
- Aqueous fluid 1295-1296, 1296f
- Aqueous humor
- age-related changes in 1286
- Arcus senilis 32, 1287
- ARDS (see Adult respiratory distress syndrome)
- Argatroban 700
- Arm, fracture of 221-222
- Aromatase inhibitors 1226t
- Arrhythmias 885-900 (see also specific arrhythmias)
- adverse drug interactions with 67t
- anesthesia effects of 260t
- anxiety and 323t
- bradyarrhythmias 895-900, 895t
- drugs for 70, 887, 888t
- sexual activity and 1159-1160
- syncope and 178
- tachyarrhythmias 885-895, 886t, 888t
- Arsenic, exposure to 1275-1276
- Arterial thromboembolism, prophylaxis of 693-697
- Arteriography (see also Angiography)
- in aortic dissection 941
- in gastrointestinal tract bleeding 1108
- Arteriosclerosis obliterans 915-920
- Arteriovenous malformations
- cerebral, hemorrhagic stroke and 416
- gastric 1110
- Arteritis, giant cell (temporal) 506-509
- Artery (arteries)
- age-related changes in 814t, 815
- carotid (see Carotid arteries)
- cerebral (see Cerebral arteries)
- coronary (see Coronary arteries)
- peripheral, disease of 915-923, 921t
- Arthritis
- cervical 1350
- degenerative (osteoarthritis) 489-493 (see also Osteoarthritis)
- gouty 495-496
- infectious (septic) 493-494
- occupational therapy for 290
- psoriatic 1254
- resources on 1411
- rheumatoid 499-503, 501t, (see also Rheumatoid arthritis)
- sexual activity and 1160
- tertiary prevention in 51
- tuberculous 764
- Arthroplasty 493
- Arthroscopy 493
- 5-ASA drugs
- in Crohn's disease 1064
- in ulcerative colitis 1061-1062
- Asbestosis 795t
- Ascorbic acid (see Vitamin C)
- Aspiration
- with intubation 791
- pneumonia and 760
- pneumonitis and 796t
- silent 759
- Aspirin (acetylsalicylic acid) 386t
- aging effect on 60t
- in angina 856, 857
- antithrombotic activity of 701-702
- in atrial fibrillation 891
- coronary artery disease and 49t
- disease prevention with 50t
- in fractures 215
- gastrointestinal tract bleeding and 1106
- in ischemic stroke 411
- after myocardial infarction 862t
- in osteoarthritis 492t
- in polycythemia vera 710
- in primary thrombocythemia 708
- sexual function and 1164t
- tinnitus with 1330t
- warfarin interaction with 68t
- Assessment (see Comprehensive geriatric assessment; Patient history; Physical examination)
- Assisted-living facilities 105t, 111
- pharmacist in 86
- Assistive devices
- amputee wheelchair 287
- for driving 237
- in gait disorders 206, 211-212
- in hearing loss 1326-1327
- Astemizole 721t
- Asterixis 432
- Asthma, anesthesia effects of 261t
- Astraphobia 327
- Ataxia 444
- Atenolol 888t
- in hypertension 843t
- in stable angina 856
- Atherosclerosis 849-853 (see also Coronary arteries, disease of)
- age-related risk for 814t-815t, 815
- cerebrovascular 402-411, 404f-405f, 406t, 407t, 408t (see also Stroke)
- parkinsonism with 444t
- in diabetes mellitus 626-627, 636
- erectile dysfunction and 1166
- in hypercoagulable states 688
- hypertension with 834, 850
- immune senescence and 1359
- occular signs of 1284
- peripheral 915-920
- postmenopausal 1210
- renal 958-959
- Athetosis 430t
- Atomic weights 1387
- Atorvastatin 617, 618t, 620t, 621
- Atrial fibrillation 886t, 890-892
- anticoagulation after 696
- in chronic mitral regurgitation 875
- in hyperthyroidism 649-650, 652
- in sick sinus syndrome 897
- Atrial flutter 890
- anticoagulation after 696
- Atrial gallop 817
- Atrial natriuretic peptide 562
- Atrial tachycardia 889-892
- with block 889
- multifocal 889
- Atrioventricular block 895t, 898-899
- Atrium, left 813, 814t
- Atrophie blanche 1252
- Atropine
- aging effect on 61t
- in bradyarrhythmias 896-897
- preoperative 255, 258
- Attention
- assessment of 348
- in delirium 351-352
- driving and 234
- Audiometry 1320-1322, 1321f
- in tinnitus 1333
- Auditory canal
- cerumen accumulation in 1334
- Auditory function, assessment of 1318-1322, 1321f
- Auranofin 503
- Auscultation
- of heart 34
- Austin-Flint murmur 870
- Autoantibodies 1356, 1357, 1359
- in bullous pemphigoid 1256
- drug-induced 680, 680t
- Autoimmune hemolysis 679, 681-682
- Autoimmunity 1359
- age-related changes in 1356, 1357
- Automatic implantable cardioverter-defibrillator
- in heart failure 910
- after myocardial infarction 863t
- in ventricular tachycardia 894
- Automobile driving (see Driving)
- Autonomic failure
- anemia of 683
- hypotension with 847
- Autopsy 127
- A-V malformations (see Arteriovenous malformation)
- A-Vo2 816t
- Axillary lymph nodes, in breast cancer 1221-1222
- Azalides 1371t
- Azathioprine
- in bullous pemphigoid 1257
- in Crohn's disease 1064t, 1065
- in dermatomyositis 526
- in Eaton-Lambert syndrome 523
- in idiopathic autoimmune hemolysis 681
- in myasthenia gravis 522
- in pulmonary interstitial disease 799
- in rheumatoid arthritis 503
- Azithromycin 1371t
- in endocarditis prophylaxis 881t
- Azlocillin 1368t
- Azoles 1376t
- Aztreonam 1370t
- in infective endocarditis 884t
|
 |
|
|
|